Whirlpool's Patent Patrol Targets Slim Microwave-Hood Clones

2026-16905, Certain Transformers and Components Thereof; Notice of Institution of Investigation

A company called Ayr Energy says some transformers and their parts imported into the U.S. are using stolen secrets and fake branding, which could hurt American businesses. The U.S. International Trade Commission is now investigating and might stop these products from being sold here. This could lead to new rules and orders soon, affecting companies selling these transformers and possibly changing what’s on store shelves.

2026-16848, Silicon Metal From Australia and Norway; Determinations

2026-16816, Hand Trucks and Certain Parts Thereof From China; Determination

2026-16811, Certain Ink Cartridges and Components Thereof II; Notice of a Commission Determination Finding a Violation Under Section 337; Issuance of a General Exclusion Order and Cease and Desist Orders; Termination of the Investigation

Notice is hereby given that the U.S. International Trade Commission has determined to find a violation under section 337 of the Tariff Act of 1930, as amended, and to issue a general exclusion order ("GEO") prohibiting the importation of products that infringe claims 1 and 7 of each of the following patents: U.S. Patent Nos. 8,764,172 ("the '172 patent"); 9,370,934 ("the '934 patent"); 11,535,038 ("the '038 patent"); 12,240,248 ("the '248 patent"); and 12,240,249 ("the '249 patent"); and cease and desist orders ("CDOs") against respondents Mountain Peak, Inc. and Straightouttaink, LP. The investigation is terminated.

2026-16667, Certain Mobile Electronic Devices; Notice of Institution of Investigation

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on July 10, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Maxell, Ltd. of Kyoto, Japan. An amended complaint was filed on July 24, 2026. The amended complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain mobile electronic devices by reason of the infringement of certain claims of U.S. Patent No. 10,812,646 ("the '646 patent"); U.S. Patent No. 12,513,408 ("the '408 patent"); U.S. Patent No. 12,061,760 ("the '760 patent"); U.S. Patent No. 12,418,692 ("the '692 patent"); U.S. Patent No. 12,185,211 ("the '211 patent"); and U.S. Patent No. 12,647,935 ("the '935 patent"). The amended complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The amended complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

2026-16581, Carbazole Violet Pigment 23 From China and India; Termination of Five-Year Reviews

The Commission instituted the subject five-year reviews on May 1, 2026 to determine whether revocation of the countervailing duty order on carbazole violet pigment 23 from India and the antidumping duty orders on carbazole violet pigment 23 from China and India would be likely to lead to continuation or recurrence of material injury. On August 7, 2026, the Department of Commerce published notice in the Federal Register that it was revoking the orders applicable August 7, 2026, because no domestic interested party filed a timely notice of intent to participate. Accordingly, the subject reviews are terminated.

Previous: 2025-23515, Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same; Institution of Investigation

AbbVie and ImmunoGen have asked the U.S. International Trade Commission to investigate certain antibody drug products imported into the U.S., claiming trade secrets were stolen. If the claim is true, this could lead to orders blocking these products from entering the U.S. and stopping unfair competition. This investigation started in December 2025 and could impact companies making or selling these drugs in the U.S., possibly affecting the market and money flow.

Next: 2025-23517, Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Extend the Sunset Date of the Current Options Regulatory Fee (ORF) From December 31, 2025 to June 30, 2026

Cboe Exchange is keeping the current Options Regulatory Fee (ORF) at $0.0023 per contract side for six more months, extending it from December 31, 2025, to June 30, 2026. This means traders and firms using Cboe Options will keep paying the same fee through mid-2026. The change kicks in right after the new year, so everyone can plan ahead without surprises!